For: | Sanal MG. Cell therapy from bench to bedside: Hepatocytes from fibroblasts - the truth and myth of transdifferentiation. World J Gastroenterol 2015; 21(21): 6427-6433 [PMID: 26074681 DOI: 10.3748/wjg.v21.i21.6427] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i21/6427.htm |
Number | Citing Articles |
1 |
Nisha Vats, Madhusudana Girija Sanal, Senthil Kumar Venugopal, Pankaj Taneja, Shiv Kumar Sarin. Cloning of human ABCB11 gene in E. coli required the removal of an intragenic Pribnow-Schaller Box before it’s Insertion into genomic safe harbor AAVS1 site using CRISPR–Cas9. F1000Research 2020; 9: 1498 doi: 10.12688/f1000research.26659.1
|
2 |
Sudarma Bogahawaththa, Suranga P. Kodithuwakku, Kavindra K. Wijesundera, Eranga H. Siriweera, Lalith Jayasinghe, Waruna L. Dissanayaka, Jayanthe Rajapakse, Chandana B. Herath, Tadayuki Tsujita, Missaka P. B. Wijayagunawardane. Anti-Fibrotic and Anti-Angiogenic Activities of Osbeckia octandra Leaf Extracts in Thioacetamide-Induced Experimental Liver Cirrhosis. Molecules 2021; 26(16): 4836 doi: 10.3390/molecules26164836
|
3 |
Abhisek Mitra, Jun Yan, Liangfang Zhang, Shulin Li. A small molecule Hedgehog agonist HhAg1.5 mediated reprogramming breaks the quiescence of noninjured liver stem cells for rescuing liver failure. Translational Research 2019; 205: 44 doi: 10.1016/j.trsl.2018.10.004
|
4 |
Wendy L van der Woerd, Roderick HJ Houwen, Stan FJ van de Graaf. Current and future therapies for inherited cholestatic liver diseases. World Journal of Gastroenterology 2017; 23(5): 763-775 doi: 10.3748/wjg.v23.i5.763
|
5 |
Timothy O. Ajiboye, Olutobi D. Ogunbiyi, Elizabeth O. Omotola, Wale J. Adeyemi, Olayinka O. Agboola, Damian C. Onwudiwe. Urine: Useless or useful “waste”?. Results in Engineering 2022; 16: 100522 doi: 10.1016/j.rineng.2022.100522
|
6 |
Mariana Jinga, Vasile Daniel Balaban, Ecaterina Bontas, Ion C. Tintoiu. Liver Diseases. 2020; : 811 doi: 10.1007/978-3-030-24432-3_74
|